Cargando…

Does procalcitonin have clinical utility in the management of paediatric community-acquired pneumonia? A PRO/CON debate

Although the overwhelming majority of community-acquired pneumonia (CAP) in children is caused by viral infections, treatment of CAP is among the most common indications for antibiotic use in children. This is largely driven by the imprecision of clinical diagnostic tools to differentiate viral from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiotos, Kathleen, Gerber, Jeffrey S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531865/ https://www.ncbi.nlm.nih.gov/pubmed/34704033 http://dx.doi.org/10.1093/jacamr/dlab153

Ejemplares similares

CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia
por: Banerjee, Ritu
Publicado: (2021)

Should ceftriaxone-resistant Enterobacterales be tested for ESBLs? A PRO/CON debate
por: Villegas, Maria Virginia, et al.
Publicado: (2021)

Pro/con clinical debate: do colloids have advantages over crystalloids in paediatric sepsis?
por: Khandelwal, Puran, et al.
Publicado: (2002)

Should serum biomarker monitoring replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapy? A PRO/CON debate
por: Harrison, Thomas, et al.
Publicado: (2022)

Pro/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?
por: Shehabi, Yahya, et al.
Publicado: (2008)

VSELs, stem cells or progenitors - A debate
por: Katoch, V.M.
Publicado: (2015)

Debating tourism degrowth post COVID-19
por: Butcher, Jim
Publicado: (2021)

The promise of paediatric dolutegravir
por: Golin, Rachel, et al.
Publicado: (2021)

The Applicability of N: Ancient Debates and Modern Experimental Design
por: van Schaik, Katherine D.
Publicado: (2018)

Pro/Con Debate: Does recombinant factor VIIa have a role to play in the treatment of patients with acute nontraumatic hemorrhage?
por: Pieri, Paola, et al.
Publicado: (2006)

Children First, a Debate on the Restrictions to Tackle COVID-19
por: Verd, Sergio
Publicado: (2023)

Human brown fat and metabolic disease: a heated debate
por: Gupta, Rana K.
Publicado: (2023)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

From “Bhang Shops” to “Cannabis in Coffee Shops”: Time to Debate the Option?
por: Balhara, Yatan Pal Singh, et al.
Publicado: (2020)

What does an orphan G-protein-coupled receptor have to do with estrogen?
por: Rae, James M, et al.
Publicado: (2005)

Revenge and catch-up travel or degrowth? Debating tourism Post COVID-19
por: Vogler, Ralf
Publicado: (2022)

Pro-Con Debate: Nitrous Oxide for Labor Analgesia
por: Vallejo, Manuel C., et al.
Publicado: (2019)

Does SDG 3 have an adequate theory of change for improving health systems performance?
por: Seidman, Gabriel
Publicado: (2017)

Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
por: Warris, Adilia
Publicado: (2021)

Does Restless Legs Syndrome Have a Different Pathomechanism in Premotor and Motor Parkinson’s Disease?
por: Calzetti, Stefano, et al.
Publicado: (2021)

Role of procalcitonin in diagnosis of community acquired pneumonia in Children
por: Ratageri, Vinod H., et al.
Publicado: (2022)

Utilization of serum procalcitonin as a biomarker in the diagnosis and treatment of children with bacterial hospital-acquired pneumonia
por: Wang, Wenlong, et al.
Publicado: (2020)

1132. Evaluating an Amoxicillin Dosing Regimen for Community Acquired Pneumonia: A Quality Improvement Initiative Using Clinical and Laboratory Data
por: Keeler, Emma, et al.
Publicado: (2021)

Pro/con clinical debate: The use of a protected specimen brush in the diagnosis of ventilator associated pneumonia
por: Heyland, Daren, et al.
Publicado: (2002)

Pro/con ethics debate: When is dead really dead?
por: Whetstine, Leslie, et al.
Publicado: (2005)

HIV misdiagnosis in paediatrics: unpacking the complexity
por: Sacks, Emma, et al.
Publicado: (2017)

Paediatric HIV: we are not done yet!
por: Penazzato, Martina
Publicado: (2020)

Procalcitonin in paediatric sepsis
por: Hatherill, M, et al.
Publicado: (1998)

The effect of vitamin C on procalcitonin biomarker in community‐acquired pneumonia
por: Nikzad, Mahsa, et al.
Publicado: (2021)

ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022)

Paediatric HIV treatment failure: a silent epidemic
por: Bernheimer, Jonathan M, et al.
Publicado: (2015)

Paediatric Care in The Netherlands: State of Affairs, Challenges and Prospects
por: Jansen, Danielle, et al.
Publicado: (2022)

It is not Black and White: A spotlight on racial diversity in paediatrics
por: Chantiluke, Kaylita, et al.
Publicado: (2022)

Pro/con clinical debate: Hydroxyethylstarches should be avoided in septic patients
por: Schortgen, Frédérique, et al.
Publicado: (2003)

Oral Immunotherapy for Food-Allergic Children: A Pro-Con Debate
por: Mori, Francesca, et al.
Publicado: (2021)

Paediatric genomic testing: Navigating medicare rebatable genomic testing
por: Sachdev, Rani, et al.
Publicado: (2021)

Paediatric genomic testing: Navigating genomic reports for the general paediatrician
por: Shah, Margit, et al.
Publicado: (2021)

Can data from paediatric cohorts solve the COVID-19 puzzle?
por: Do, Lien Anh Ha, et al.
Publicado: (2020)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD
por: Çolak, Ayfer, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qvik2virecbqenk9eq44fu9c8v